Genus Capital Management’s Scotiabank BNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.18M Hold
36,605
0.31% 90
2026
Q1
$2.53M Sell
36,605
-5,415
-13% -$397K 0.29% 105
2025
Q4
$3.1M Buy
42,020
+1,846
+5% +$125K 0.36% 82
2025
Q3
$2.6M Buy
40,174
+7,480
+23% +$441K 0.3% 103
2025
Q2
$1.8M Buy
32,694
+8,644
+36% +$440K 0.23% 110
2025
Q1
$1.14M Buy
+24,050
New +$1.21M 0.17% 118
2024
Q2
Sell
-114,778
Closed -$5.44M 222
2024
Q1
$5.94M Buy
+114,778
New +$5.5M 0.77% 40
2023
Q4
Sell
-18,846
Closed -$830K 219
2023
Q3
$849K Sell
18,846
-830
-4% -$39.8K 0.13% 130
2023
Q2
$986K Buy
+19,676
New +$976K 0.15% 135

Other funds holding BNS

Genus Capital Management's BNS Position: Q2 2026 in Review

Genus Capital Management held its Scotiabank (BNS) position steady in Q2 2026 at 36,605 shares worth $3.18M. The position accounts for 0.31% of the portfolio, ranked #90.

Genus Capital Management first reported a position in BNS in Q2 2023 and has held it in 9 quarters since. The position peaked at $5.94M in Q1 2024. 532 funds tracked by Wall St. Rank hold BNS as of Q2 2026.

  • Genus Capital Management held 36,605 shares of Scotiabank worth $3.18M as of Q2 2026.
  • Genus Capital Management left its Scotiabank share count unchanged in Q2 2026.
  • Scotiabank made up 0.31% of Genus Capital Management's portfolio in Q2 2026, its #90 holding.
  • Genus Capital Management first reported a position in Scotiabank in Q2 2023 and has held it in 9 quarters since.
  • Genus Capital Management's Scotiabank position peaked at $5.94M in Q1 2024.
  • 532 funds tracked by Wall St. Rank held Scotiabank as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.